Antonino Asaro

Antonino Asaro

Auto-generated profile, based on publicly available information

Antonino Asaro

Institute of Bioengineering and Global Health Institute, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2016 in eLife
Verified
Journal Article
Open access
SMShane J Morley
Shane J Morley
YQYanmei Qi
Yanmei Qi
LILoredana Iovino
Loredana Iovino
LALaura Andolfi
Laura Andolfi
DGDa Guo
Da Guo
PHPaul A Heppenstall
Paul A Heppenstall
At its most fundamental level, touch sensation requires the translation of mechanical energy into mechanosensitive ion channel opening, thereby generating electro-chemical signals. Our understanding of this process, especially how the cytoskeleton influences it, remains unknown. Here we demonstrate that mice lacking the α-tubulin acetyltransferase Atat1 in sensory neurons display profound deficits in their ability to detect mechanical stimuli. We show that all cutaneous afferent subtypes, including nociceptors have strongly reduced mechanosensitivity upon Atat1 deletion, and that consequently, mice are largely insensitive to mechanical touch and pain. We establish that this broad loss of mechanosensitivity is dependent upon the acetyltransferase activity of Atat1, which when absent leads to a decrease in cellular elasticity. By mimicking α-tubulin acetylation genetically, we show both cellular rigidity and mechanosensitivity can be restored in Atat1 deficient sensory neurons. Hence, our results indicate that by influencing cellular stiffness, α-tubulin acetylation sets the force required for touch.

8 December 2014 in Nature Methods
Verified
Journal Article
Closed access
GYGuoying Yang
Guoying Yang
FRFernanda de Castro Reis
Fernanda de Castro Reis
MSMayya Sundukova
Mayya Sundukova
SPSofia Pimpinella
Sofia Pimpinella
AAAntonino Asaro
Antonino Asaro
PHPaul A Heppenstall
Paul A Heppenstall

1 March 2019 in Cell Reports
Verified
Journal Article
Open access
AMAnna Malik
Anna Malik
KSKinga Szydlowska
Kinga Szydlowska
KNKarolina Nizinska
Karolina Nizinska
AAAntonino Asaro
Antonino Asaro
EVErwin van Vliet
Erwin van Vliet
TWThomas E. Willnow
Thomas E. Willnow
VPS10P domain receptors emerge as central regulators of intracellular protein sorting in neurons with relevance for various brain pathologies. Here, we identified a role for the family member SorCS2 in protection of neurons from oxidative stress and epilepsy-induced cell death. We show that SorCS2 acts as sorting receptor that sustains cell surface expression of the neuronal amino acid transporter EAAT3 to facilitate import of cysteine, required for synthesis of the reactive oxygen species scavenger glutathione. Lack of SorCS2 causes depletion of EAAT3 from the plasma membrane and impairs neuronal cysteine uptake. As a consequence, SorCS2-deficient mice exhibit oxidative brain damage that coincides with enhanced neuronal cell death and increased mortality during epilepsy. Our findings highlight a protective role for SorCS2 in neuronal stress response and provide a possible explanation for upregulation of this receptor seen in surviving neurons of the human epileptic brain.

3 January 2020 in Glia
Verified
Journal Article
Open access
PDF file
AMAnna Malik
Anna Malik
JLJanet Lips
Janet Lips
MGMalgorzata Gorniak‐Walas
Malgorzata Gorniak‐Walas
DBDiede W. M. Broekaart
Diede W. M. Broekaart
AAAntonino Asaro
Antonino Asaro
TWThomas E. Willnow
Thomas E. Willnow
SorCS2 is an intracellular sorting receptor of the VPS10P domain receptor gene family recently implicated in oxidative stress response. Here, we interrogated the relevance of stress‐related activities of SorCS2 in the brain by exploring its role in ischemic stroke in mouse models and in patients. Although primarily seen in neurons in the healthy brain, expression of SorCS2 was massively induced in astrocytes surrounding the ischemic core in mice following stroke. Post‐stroke induction was likely a result of increased levels of transforming growth factor β1 in damaged brain tissue, inducing Sorcs2 gene transcription in astrocytes but not neurons. Induced astrocytic expression of SorCS2 was also seen in stroke patients, substantiating the clinical relevance of this observation. In astrocytes in vitro and in the mouse brain in vivo, SorCS2 specifically controlled release of endostatin, a factor linked to post‐stroke angiogenesis. The ability of astrocytes to release endostatin acutely after stroke was lost in mice deficient for SorCS2, resulting in a blunted endostatin response which coincided with impaired vascularization of the ischemic brain. Our findings identified activated astrocytes as a source for endostatin in modulation of post‐stroke angiogenesis, and the importance of the sorting receptor SorCS2 in this brain stress response.

25 June 2020 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PDF file
AAAntonino Asaro
Antonino Asaro
ACAnne‐Sophie Carlo‐Spiewok
Anne‐Sophie Carlo‐Spiewok
AMAnna Malik
Anna Malik
MRMichael Rothe
Michael Rothe
CSCarola G. Schipke
Carola G. Schipke
TWThomas E. Willnow
Thomas E. Willnow
Introduction: Apolipoprotein E (apoE) is a carrier for brain lipids and the most important genetic risk factor for Alzheimer's disease (AD). ApoE binds the receptor sortilin, which mediates uptake of apoE‐bound cargo into neurons. The significance of this uptake route for brain lipid homeostasis and AD risk seen with apoE4, but not apoE3, remains unresolved.Methods: Combining neurolipidomics in patient specimens with functional studies in mouse models, we interrogated apoE isoform–specific functions for sortilin in brain lipid metabolism and AD.Results: Sortilin directs the uptake and conversion of polyunsaturated fatty acids into endocannabinoids, lipid‐based neurotransmitters that act through nuclear receptors to sustain neuroprotective gene expression in the brain. This sortilin function requires apoE3, but is disrupted by binding of apoE4, compromising neuronal endocannabinoid metabolism and action.Discussion: We uncovered the significance of neuronal apoE receptor sortilin in facilitating neuroprotective actions of brain lipids, and its relevance for AD risk seen with apoE4.

21 October 2021 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
AAAntonino Asaro
Antonino Asaro
RSRishabhdev Sinha
Rishabhdev Sinha
MBMagda Bakun
Magda Bakun
OKOleksandra Kalnytska
Oleksandra Kalnytska
ACAnne-Sophie Carlo-Spiewok
Anne-Sophie Carlo-Spiewok
TWThomas E. Willnow
Thomas E. Willnow
Sortilin is a neuronal receptor for apolipoprotein E (apoE). Sortilin-dependent uptake of lipidated apoE promotes conversion of polyunsaturated fatty acids (PUFA) into neuromodulators that induce anti-inflammatory gene expression in the brain. This neuroprotective pathway works with the apoE3 variant but is lost with the apoE4 variant, the main risk factor for Alzheimer's disease (AD). Here, we elucidated steps in cellular handling of lipids through sortilin, and why they are disrupted by apoE4. Combining unbiased proteome screens with analyses in mouse models, we uncover interaction of sortilin with fatty acid-binding protein 7 (FABP7), the intracellular carrier for PUFA in the brain. In the presence of apoE3, sortilin promotes functional expression of FABP7 and its ability to elicit lipid-dependent gene transcription. By contrast, apoE4 binding blocks sortilin-mediated sorting, causing catabolism of FABP7 and impairing lipid signaling. Reduced FABP7 levels in the brain of AD patients expressing apoE4 substantiate the relevance of these interactions for neuronal lipid homeostasis. Taken together, we document interaction of sortilin with mediators of extracellular and intracellular lipid transport that provides a mechanistic explanation for loss of a neuroprotective lipid metabolism in AD.